BSE - Delayed Quote
INR
Aurobindo Pharma Limited (AUROPHARMA.BO)
1,677.80
+22.80
(+1.38%)
At close: October 30 at 3:52:15 PM GMT+5:30
Earnings Trends
Earnings Per Share
Revenue vs. Earnings
Q2 FY26
Revenue
82.86B
Earnings
8.48B
Profit Margin
10.24%
Q3
FY25
Q4
FY25
Q1
FY26
Q2
FY26
0
20B
40B
60B
80B
10.3%
10.4%
10.5%
10.6%
10.7%
Revenue Estimate
| Currency in INR
|
Current Qtr. (Dec 2025)
|
Next Qtr. (Mar 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
17 | 2 | 25 | 25 |
|
Avg. Estimate
|
84.8B | 84.52B | 332.27B | 370.98B |
|
Low Estimate
|
80.65B | 84.29B | 314.04B | 350.48B |
|
High Estimate
|
87.61B | 84.76B | 341.44B | 411.65B |
|
Year Ago Sales
|
79.79B | 83.82B | 317.24B | 332.27B |
|
Sales Growth (year/est)
|
6.29% | 0.84% | 4.74% | 11.65% |
Earnings Estimate
| Currency in INR
|
Current Qtr. (Dec 2025)
|
Next Qtr. (Mar 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
8 | 1 | 25 | 26 |
|
Avg. Estimate
|
15.89 | 16.88 | 61.67 | 74.94 |
|
Low Estimate
|
15.1 | 16.88 | 53.1 | 62.76 |
|
High Estimate
|
16.5 | 16.88 | 65.5 | 91.5 |
|
Year Ago EPS
|
14.56 | 15.56 | 59.81 | 61.67 |
Earnings History
| Currency in INR
|
12/31/2024
|
3/31/2025
|
6/30/2025
|
9/30/2025
|
|---|---|---|---|---|
|
EPS Est.
|
15.54 | 17.79 | 16.49 | 15.24 |
|
EPS Actual
|
14.56 | 15.56 | 14.2 | 14.61 |
|
Difference
|
-0.98 | -2.23 | -2.29 | -0.63 |
|
Surprise %
|
-6.30% | -12.51% | -13.89% | -4.14% |
EPS Trend
| Currency in INR
|
Current Qtr. (Dec 2025)
|
Next Qtr. (Mar 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
15.89 | 16.88 | 61.67 | 74.94 |
|
7 Days Ago
|
15.9 | 16.94 | 61.95 | 74.87 |
|
30 Days Ago
|
16.41 | 17 | 62.14 | 74.93 |
|
60 Days Ago
|
16.4 | 15.45 | 62.14 | 74.85 |
|
90 Days Ago
|
16.41 | 17.49 | 64.42 | 75.12 |
EPS Revisions
| Currency in INR
|
Current Qtr. (Dec 2025)
|
Next Qtr. (Mar 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | 1 | 2 |
|
Up Last 30 Days
|
-- | -- | 3 | 4 |
|
Down Last 7 Days
|
-- | 1 | -- | -- |
|
Down Last 30 Days
|
-- | 1 | 3 | 4 |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
AUROPHARMA.BO
|
9.10% | 8.46% | 3.11% | 21.52% |
|
S&P 500
|
26.99% | 26.80% | 32.87% | 16.85% |
